DK0773221T3 - Stabile krystallinske tetrahydrofolsyre-salte - Google Patents

Stabile krystallinske tetrahydrofolsyre-salte

Info

Publication number
DK0773221T3
DK0773221T3 DK96116403T DK96116403T DK0773221T3 DK 0773221 T3 DK0773221 T3 DK 0773221T3 DK 96116403 T DK96116403 T DK 96116403T DK 96116403 T DK96116403 T DK 96116403T DK 0773221 T3 DK0773221 T3 DK 0773221T3
Authority
DK
Denmark
Prior art keywords
tetrahydrofolic acid
acid salts
stable crystalline
crystalline tetrahydrofolic
water
Prior art date
Application number
DK96116403T
Other languages
Danish (da)
English (en)
Inventor
Hans Rudolf Mueller
Rudolf Moser
Martin Ulmann
Thomas Ammann
Original Assignee
Eprova Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eprova Ag filed Critical Eprova Ag
Application granted granted Critical
Publication of DK0773221T3 publication Critical patent/DK0773221T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
DK96116403T 1995-11-07 1996-10-14 Stabile krystallinske tetrahydrofolsyre-salte DK0773221T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH03145/95A CH689831A5 (de) 1995-11-07 1995-11-07 Stabile kristalline Tetrahydrofolsaeure-Salze.

Publications (1)

Publication Number Publication Date
DK0773221T3 true DK0773221T3 (da) 2000-07-10

Family

ID=4249585

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96116403T DK0773221T3 (da) 1995-11-07 1996-10-14 Stabile krystallinske tetrahydrofolsyre-salte

Country Status (19)

Country Link
US (1) US5817659A (es)
EP (1) EP0773221B1 (es)
JP (1) JP3382103B2 (es)
KR (2) KR100296162B1 (es)
CN (1) CN1067392C (es)
AT (1) ATE191482T1 (es)
AU (1) AU707443B2 (es)
CA (1) CA2187409C (es)
CH (1) CH689831A5 (es)
DE (1) DE59604878D1 (es)
DK (1) DK0773221T3 (es)
ES (1) ES2145360T3 (es)
GR (1) GR3033727T3 (es)
HU (1) HUP9603072A3 (es)
NO (1) NO964699L (es)
PT (1) PT773221E (es)
RU (1) RU2187508C2 (es)
TW (1) TW533214B (es)
ZA (1) ZA969284B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH693255A5 (de) * 1997-06-13 2003-05-15 Eprova Ag Verwendung von Tetrahydrofolaten in der natürlichenstereoisomeren Form zur Herstellung einer pharmazeutischenZubereitung geeignet zur Beeinflussung des Homocystein-Spiegels.
AU1223400A (en) * 1998-10-22 2000-05-08 Phillip B. B. Moheno Novel pterin antineoplastic agents
CH693905A5 (de) * 1999-04-15 2004-04-15 Eprova Ag Stabile kristalline Salze von 5-Methyltetrahydrofolsäure.
CH694251A5 (de) 1999-07-14 2004-10-15 Eprova Ag Herstellung von Tetrahydropterin und Derivaten.
FR2816944B1 (fr) * 2000-11-17 2005-10-21 Dospharma Nouveaux sels de lithium, les compositions pharmaceutiques a base de ces sels de lithium et leurs applications comme medicament
ATE498401T1 (de) * 2004-09-15 2011-03-15 Nipro Corp Wässrige, stabile (6s)-folinsäurelösung zur injektion
ES2538480T3 (es) * 2008-02-20 2015-06-22 Gnosis S.P.A. Folatos, composiciones y usos de los mismos
US7947662B2 (en) 2008-02-20 2011-05-24 Gnosis S.P.A. Folates, compositions and uses thereof
US9629846B1 (en) 2013-11-14 2017-04-25 Argent Development Group, Llc Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women
US9492421B1 (en) 2013-11-14 2016-11-15 Argent Development Group, Llc Nutritional supplements for treatment of iron deficiency anemia
WO2016185413A1 (en) 2015-05-20 2016-11-24 Nestec S.A. Modified release formulations
JP7296885B2 (ja) 2017-03-31 2023-06-23 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング ５－メチル－（６ｓ）－テトラヒドロ葉酸の結晶性ナトリウム塩
PT3609894T (pt) 2017-03-31 2024-08-29 Merck Patent Gmbh Sal de sódio cristalino do ácido 5-metil-(6s)-tetrahidrofólico
EP3461826A1 (en) 2017-09-29 2019-04-03 Aprofol AG Multifunctional folate salts
CN108976232A (zh) * 2018-09-19 2018-12-11 江苏红豆杉药业有限公司 一种四氢叶酸钙的合成方法
EP3646873A1 (en) 2018-10-31 2020-05-06 Aprofol AG Folate salts
CN109456330B (zh) * 2018-11-26 2021-05-14 连云港德洋化工有限公司 叶酸类稳定复合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124452A (en) * 1978-07-10 1992-06-23 Bioresearch S.P.A. Process for producing d,1-5-methyltetrahydrofolic acid and its salts
MX169933B (es) * 1987-09-18 1993-08-02 Hideaki Yamada Procedimiento para la produccion biologica de amidas
DE3821875C1 (es) * 1988-06-29 1990-02-15 Eprova Ag, Forschungsinstitut, Schaffhausen, Ch
CH681303A5 (es) * 1991-01-16 1993-02-26 Eprova Ag
CH684270A5 (de) * 1991-10-04 1994-08-15 Sapec Fine Chemicals Verfahren zur Herstellung von Erdalkalimetallsalzen von (6R)-N(10)-Formyl-5,6,7,8-tetrahydrofolsäure.
CH686672A5 (de) * 1992-12-01 1996-05-31 Cerbios Pharma Sa Verfahren zur Herstellung von (6S)-5,6,7,8-Tetrahydrofolsaeure.
GEP20012441B (en) * 1993-04-02 2001-05-25 Lonza Ag Process for Preparing 3-Methylpiperidine and 3-Methylpyridine
CH686369A5 (de) * 1994-05-09 1996-03-15 Eprova Ag Stabile kristalline (6S)- und (6R)-Tetrahydrofolseure.
CZ338596A3 (en) * 1994-05-23 1997-07-16 Lonza Ag Catalytic mixture for oxidative amonolysis of alkyl pyridines, process of its preparation and use

Also Published As

Publication number Publication date
HUP9603072A2 (en) 1997-08-28
ZA969284B (en) 1997-05-07
GR3033727T3 (en) 2000-10-31
KR100702201B1 (ko) 2007-11-12
NO964699D0 (no) 1996-11-06
TW533214B (en) 2003-05-21
CN1067392C (zh) 2001-06-20
CA2187409C (en) 2000-08-22
NO964699L (no) 1997-05-09
HUP9603072A3 (en) 1998-01-28
AU707443B2 (en) 1999-07-08
EP0773221B1 (de) 2000-04-05
ATE191482T1 (de) 2000-04-15
DE59604878D1 (de) 2000-05-11
KR970027048A (ko) 1997-06-24
RU2187508C2 (ru) 2002-08-20
EP0773221A1 (de) 1997-05-14
CH689831A5 (de) 1999-12-15
CA2187409A1 (en) 1997-05-08
AU7053396A (en) 1997-05-15
ES2145360T3 (es) 2000-07-01
JPH09169759A (ja) 1997-06-30
KR100296162B1 (ko) 2001-09-10
HU9603072D0 (en) 1996-12-30
US5817659A (en) 1998-10-06
KR970027056A (ko) 1997-06-24
JP3382103B2 (ja) 2003-03-04
PT773221E (pt) 2000-09-29
CN1153176A (zh) 1997-07-02

Similar Documents

Publication Publication Date Title
DK0773221T3 (da) Stabile krystallinske tetrahydrofolsyre-salte
ES2118283T3 (es) Derivados de acidos benzofuranil- y -tiofenil-alcanocarboxilicos.
NO20001886D0 (no) Stabile, krystallinske salter av 5-metyltetrahydrofolsyre og fremgangsmõte til fremstilling derav
RU96121625A (ru) Стабильная кристаллическая соль тетрагидрофолиевой кислоты
NO962321L (no) Nye krystallformer av vannfritt 7-([1,5,6Å-6-amino-3-azabicyklo [3.1.0Å heks-3-yl)-6-fluoro-1-2,4-difluorfenyl)-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyre-metansulfonsyresalt
KR950032192A (ko) 안정한 결정성의 (6s)- 및 (6r)-테트라히드로폴산
KR840007878A (ko) 벤조퀴놀리진 카르복실산 유도체의 제조방법
DE3668621D1 (de) Verfahren zur herstellung von pteridinderivaten.
ATE79624T1 (de) 3h-1,2,3-triazolo(4,5-d>pyrimidine.
MX9304719A (es) Proceso para la cristalizacion de aspartama.
NO933367D0 (no) Sterkt vannloeselige, stablie, krystallinske salter av 2',3'-dideoksyinosin, 2',3'-dideoksy-2',3'didehydrotymidin og2',3'dideoksy-2'-fluorisin, og fremgangsmaate til fremstilling derav
YU53694A (sh) Kristali antimikrobnog jedinjenja
KR880003955A (ko) 페니실린 유도체의 수화물 및 그 제조방법
ATE156824T1 (de) Verfahren zur herstellung von pyrido(1,2- a>pyrimidinderivaten
KR830009115A (ko) 세파드록신 모노하이드레이트의 제조방법
TH19997EX (th) ผลึกของสารประกอบต่อต้านการเจริญของจุลินทรีย์
HUT57779A (en) Process for producing new thiazetoquinoline-3-carboxylic acid derivatives